Acorda regains licensing rights of high-quality MS drug Fampyra from Biogen by Editor | Jan 14, 2024 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0 USA – Acorda Therapeutics has regained the licensing rights for multiple sclerosis (MS) drug,... Read More
The National Multiple Sclerosis Society launched in Abu Dhabi by Editor | Apr 17, 2023 | AFRICAN & MIDDLE EAST NEWS, Diseases News, LATEST NEWS, NGOs, Associations & Development Partners | 0 UAE – The United Arab Emirates’ Ministry of Community Development has introduced its new... Read More
Kenya explores pharma prospects in manufacturing drugs for treatment of multiple sclerosis by Editor | Jun 6, 2022 | AFRICAN & MIDDLE EAST NEWS, Diseases News, Government, Regulatory & Policy News, Hospitals, LATEST NEWS | 0 KENYA – Kenya’s Ministry of Health is in discussions with health stakeholders to commence local... Read More